GenMark Diagnostics Company Profile (NASDAQ:GNMK)

About GenMark Diagnostics

GenMark Diagnostics logoGenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company. The Company focuses on developing and commercializing its eSensor detection technology. Its eSensor electrochemical technology detects multiple distinct biomarkers in a single sample. It sells its XT-8 instrument and related diagnostic and research tests (XT-8 system) in the United States. It has developed and intends to commercially launch its sample-to-answer ePlex instrument and its associated diagnostic tests, which it collectively refers to as its ePlex system, in Europe and the United States. It operates in the development, manufacturing, sales and support of instruments and molecular tests based on its eSensor detection technology segment. Over four of its diagnostic tests, which run on its XT-8 instrument, have received United States Food and Drug Administration clearance, including Cystic Fibrosis Genotyping Test, Warfarin Sensitivity Test, Thrombophilia Risk Test and Respiratory Viral Panel.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GNMK
  • CUSIP:
Key Metrics:
  • Previous Close: $8.74
  • 50 Day Moving Average: $9.53
  • 200 Day Moving Average: $7.17
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -10.06
  • P/E Growth: 5.94
  • Market Cap: $376.19M
  • Outstanding Shares: 42,993,000
  • Beta: 0.42
Additional Links:
Companies Related to GenMark Diagnostics:

Analyst Ratings

Consensus Ratings for GenMark Diagnostics (NASDAQ:GNMK) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $10.29 (17.62% upside)

Analysts' Ratings History for GenMark Diagnostics (NASDAQ:GNMK)
DateFirmActionRatingPrice TargetDetails
7/29/2016Canaccord GenuityReiterated RatingBuy$13.00View Rating Details
7/29/2016JPMorgan Chase & Co.Boost Price TargetOverweight$10.00 -> $13.00View Rating Details
6/17/2016Needham & Company LLCInitiated CoverageBuy$11.00 -> $13.00View Rating Details
2/26/2016Raymond James Financial Inc.Lower Price TargetOutperform$9.00 -> $7.25View Rating Details
2/26/2016Cowen and CompanyLower Price Target$7.25 -> $6.50View Rating Details
2/24/2016BTIG ResearchReiterated RatingBuy$9.00View Rating Details
(Data available from 8/27/2014 forward)


Earnings History for GenMark Diagnostics (NASDAQ:GNMK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q216($0.33)($0.30)$9.62 million$12.50 millionViewListenView Earnings Details
5/3/2016Q116($0.29)($0.30)$10.67 million$11.06 millionViewN/AView Earnings Details
2/23/2016Q415($0.27)($0.21)$12.34 million$13.20 millionViewListenView Earnings Details
10/27/2015Q315($0.31)($0.27)$8.24 million$8.80 millionViewListenView Earnings Details
8/6/2015Q215($0.31)($0.29)$7.59 million$7.65 millionViewN/AView Earnings Details
5/5/2015Q115($0.24)($0.24)$10.10 million$10.10 millionViewN/AView Earnings Details
2/24/2015Q414($0.28)($0.21)ViewN/AView Earnings Details
10/30/2014Q314($0.32)($0.23)$5.80 million$6.30 millionViewN/AView Earnings Details
8/11/2014Q214($0.29)($0.27)$4.79 million$6.55 millionViewN/AView Earnings Details
5/6/2014Q114($0.25)($0.21)$6.40 million$7.91 millionViewN/AView Earnings Details
3/11/2014Q413($0.22)($0.21)$6.06 million$6.45 millionViewN/AView Earnings Details
11/12/2013Q313($0.27)($0.24)$4.60 million$4.64 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.26)($0.25)$5.05 million$5.20 millionViewN/AView Earnings Details
5/8/2013Q1 2013($0.17)($0.13)$9.53 million$11.10 millionViewN/AView Earnings Details
11/10/2011($0.32)($0.31)ViewN/AView Earnings Details
8/5/2011($0.45)($0.39)ViewN/AView Earnings Details
5/9/2011($0.49)($0.56)ViewN/AView Earnings Details
3/3/2011($0.52)($0.30)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for GenMark Diagnostics (NASDAQ:GNMK)
Current Year EPS Consensus Estimate: $-1.16 EPS
Next Year EPS Consensus Estimate: $-0.87 EPS


Dividend History for GenMark Diagnostics (NASDAQ:GNMK)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for GenMark Diagnostics (NASDAQ:GNMK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/22/2016Michael GleesonSVPSell7,500$9.00$67,500.00View SEC Filing  
8/12/2016Lisa M GilesDirectorBuy823$9.40$7,736.20View SEC Filing  
8/2/2016Eric StierSVPSell367$9.88$3,625.96View SEC Filing  
8/2/2016Hany MassaranyInsiderSell1,147$9.88$11,332.36View SEC Filing  
6/7/2016Hany MassaranyCEOSell1,188$8.98$10,668.24View SEC Filing  
6/7/2016Michael GleesonSVPSell868$8.80$7,638.40View SEC Filing  
6/3/2016Ingo ChakravartySVPSell184$8.53$1,569.52View SEC Filing  
5/9/2016Ingo ChakravartySVPSell582$5.42$3,154.44View SEC Filing  
5/2/2016Eric StierSVPSell363$5.79$2,101.77View SEC Filing  
5/2/2016Hany MassaranyCEOSell1,160$5.79$6,716.40View SEC Filing  
3/10/2016Michael KagnoffDirectorBuy2,500$4.90$12,250.00View SEC Filing  
3/7/2016Hany MassaranyCEOSell1,193$5.76$6,871.68View SEC Filing  
3/7/2016Michael GleesonSVPSell559$5.76$3,219.84View SEC Filing  
3/2/2016Eric StierSVPSell365$4.87$1,777.55View SEC Filing  
2/9/2016Ingo ChakravartySVPSell697$5.04$3,512.88View SEC Filing  
2/3/2016Hany MassaranyCEOSell9,173$4.99$45,773.27View SEC Filing  
2/3/2016Michael GleesonSVPSell3,083$4.99$15,384.17View SEC Filing  
1/21/2016Hany MassaranyCEOSell648$6.80$4,406.40View SEC Filing  
1/21/2016Michael GleesonSVPSell227$6.80$1,543.60View SEC Filing  
12/8/2015Eric StierSVPSell240$7.26$1,742.40View SEC Filing  
12/8/2015Hany MassaranyCEOSell1,735$7.26$12,596.10View SEC Filing  
12/3/2015Hany MassaranyCEOSell3,571$7.71$27,532.41View SEC Filing  
12/3/2015Michael GleesonSVPSell1,664$7.62$12,679.68View SEC Filing  
11/3/2015Lisa M GilesDirectorBuy4,000$6.60$26,400.00View SEC Filing  
10/30/2015Michael KagnoffDirectorBuy5,000$6.70$33,500.00View SEC Filing  
10/30/2015Scott MendelCFOBuy10,000$6.47$64,700.00View SEC Filing  
10/29/2015Daryl FaulknerDirectorBuy4,000$7.33$29,320.00View SEC Filing  
9/15/2015Jennifer Anne WilliamsSVPSell14,245$9.98$142,165.10View SEC Filing  
9/14/2015Jennifer Anne WilliamsSVPSell9,245$10.00$92,450.00View SEC Filing  
9/11/2015Hany MassaranyCEOSell1,683$9.64$16,224.12View SEC Filing  
9/11/2015Jennifer Anne WilliamsSVPSell18,280$9.99$182,617.20View SEC Filing  
9/4/2015Jennifer Anne WilliamsSVPSell1,867$9.59$17,904.53View SEC Filing  
9/2/2015Hany MassaranyCEOSell3,865$9.62$37,181.30View SEC Filing  
8/24/2015Scott MendelCFOBuy10,000$9.10$91,000.00View SEC Filing  
6/16/2015Hany MassaranyCEOSell1,698$9.12$15,485.76View SEC Filing  
6/4/2015Michael GleesonSVPSell1,595$9.55$15,232.25View SEC Filing  
6/3/2015Hany MassaranyCEOSell3,486$9.47$33,012.42View SEC Filing  
4/9/2015Hany MassaranyCEOSell5,942$11.52$68,451.84View SEC Filing  
3/13/2015Jennifer Anne WilliamsSVPSell30,000$12.56$376,800.00View SEC Filing  
3/11/2015Hany MassaranyCEOSell28,110$11.88$333,946.80View SEC Filing  
3/11/2015Jeffrey Alan HawkinsSVPSell6,832$12.01$82,052.32View SEC Filing  
3/10/2015Jennifer Anne WilliamsSVPSell722$11.83$8,541.26View SEC Filing  
3/10/2015Michael KagnoffDirectorBuy5,000$11.84$59,200.00View SEC Filing  
3/9/2015Ingo ChakravartySVPSell3,310$12.06$39,918.60View SEC Filing  
1/22/2015Hany MassaranyCEOSell5,982$12.88$77,048.16View SEC Filing  
1/7/2015Hany MassaranyCEOSell4,858$13.00$63,154.00View SEC Filing  
12/16/2014Kevin C OboyleDirectorSell291$12.40$3,608.40View SEC Filing  
12/15/2014Eric StierSVPSell235$12.51$2,939.85View SEC Filing  
12/15/2014Hany MassaranyCEOSell1,700$12.51$21,267.00View SEC Filing  
12/4/2014Hany MassaranyCEOSell3,300$12.06$39,798.00View SEC Filing  
12/4/2014Jeffrey Alan HawkinsSVPSell1,350$12.06$16,281.00View SEC Filing  
10/31/2014Jon Faiz KayyemSVPSell6,000$11.01$66,060.00View SEC Filing  
10/8/2014Hany MassaranyCEOSell5,804$9.00$52,236.00View SEC Filing  
10/7/2014Michael GleesonSVPSell55$9.10$500.50View SEC Filing  
9/12/2014Hany MassaranyCEOSell1,678$9.86$16,545.08View SEC Filing  
9/5/2014Hany MassaranyCEOSell3,795$10.04$38,101.80View SEC Filing  
9/5/2014Michael GleesonSVPSell1,833$10.04$18,403.32View SEC Filing  
8/7/2014Michael GleesonSVPSell52$11.15$579.80View SEC Filing  
7/1/2014Jon Faiz KayyemSVPSell6,000$13.60$81,600.00View SEC Filing  
6/11/2014Hany MassaranyCEOSell1,115$11.64$12,978.60View SEC Filing  
6/5/2014Jon Faiz KayyemSVPSell1,483$10.69$15,853.27View SEC Filing  
6/3/2014Hany MassaranyCEOSell2,700$10.67$28,809.00View SEC Filing  
5/29/2014Kevin C OboyleDirectorSell1,603$10.98$17,600.94View SEC Filing  
5/28/2014Jon Faiz KayyemSVPSell6,000$11.06$66,360.00View SEC Filing  
5/8/2014Richard SlanskyCFOSell2,302$9.26$21,316.52View SEC Filing  
4/9/2014Hany MassaranyCEOSell3,985$9.87$39,331.95View SEC Filing  
3/26/2014Jennifer Anne WilliamsSVPSell30,195$9.97$301,044.15View SEC Filing  
3/5/2014Jon Faiz KayyemSVPSell7,355$12.46$91,643.30View SEC Filing  
1/16/2014Jon Faiz KayyemSVPSell50,000$14.05$702,500.00View SEC Filing  
1/7/2014Hany MassaranyCEOSell4,698$13.31$62,530.38View SEC Filing  
12/6/2013Michael GleesonSVPSell2,211$11.14$24,630.54View SEC Filing  
12/4/2013Hany MassaranyCEOSell3,968$11.14$44,203.52View SEC Filing  
10/9/2013Hany MassaranyCEOSell3,925$12.05$47,296.25View SEC Filing  
10/1/2013Jon Faiz KayyemSVPSell6,000$12.14$72,840.00View SEC Filing  
9/4/2013Jeffrey Alan HawkinsSVPSell1,890$11.60$21,924.00View SEC Filing  
9/3/2013Hany MassaranyCEOSell2,354$11.60$27,306.40View SEC Filing  
9/3/2013Jon Faiz KayyemSVPSell1,545$11.60$17,922.00View SEC Filing  
8/20/2013Jon Faiz KayyemSVPSell1,310$10.15$13,296.50View SEC Filing  
7/1/2013Jon Faiz KayyemSVPSell6,000$10.40$62,400.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for GenMark Diagnostics (NASDAQ:GNMK)
DateHeadline logoWill GenMark Diagnostics, Inc. (NASDAQ:GNMK) Hit $12 Price Target? - Investor Newswire (NASDAQ:GNMK) - August 19 at 5:16 PM
News IconInsider Trading Recap: GenMark Diagnostics, Inc (NASDAQ:GNMK) - The Voice Registrar (NASDAQ:GNMK) - August 17 at 5:28 PM logoGenMark Diagnostics, Inc. breached its 50 day moving average in a Bearish Manner : GNMK-US : August 17, 2016 (NASDAQ:GNMK) - August 17 at 5:28 PM logoETF’s with exposure to GenMark Diagnostics, Inc. : August 16, 2016 (NASDAQ:GNMK) - August 16 at 5:26 PM logoGenMark Diagnostics, Inc. :GNMK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:GNMK) - August 10 at 5:33 PM logoJP Morgan Maintains GenMark Diagnostics Inc to Overweight with Price Target $13.00 - Trade Calls (NASDAQ:GNMK) - August 9 at 8:12 AM logoStrong Sell Calls For GenMark Diagnostics, Inc. (NASDAQ:GNMK) At 0 - Investor Newswire (NASDAQ:GNMK) - August 6 at 8:09 AM logoGenMark Diagnostics Inc. (GNMK) is Trading Higher on Unusual Volume for August 03 - (NASDAQ:GNMK) - August 5 at 8:12 AM logoGENMARK DIAGNOSTICS, INC. Financials (NASDAQ:GNMK) - August 4 at 5:36 PM logoWill GenMark Diagnostics, Inc. (NASDAQ:GNMK) Surprise Analysts? - Investor Newswire (NASDAQ:GNMK) - August 3 at 5:33 PM logoGenMark Diagnostics Inc. (GNMK) is Trading Lower on Unusual Volume for August 01 - (NASDAQ:GNMK) - August 3 at 8:20 AM logoEdited Transcript of GNMK earnings conference call or presentation 28-Jul-16 8:30pm GMT (NASDAQ:GNMK) - July 30 at 11:08 PM logoCan Shares Of GenMark Diagnostics, Inc. (NASDAQ:GNMK) Hit $15? - Investor Newswire (NASDAQ:GNMK) - July 30 at 8:09 AM logoGenMark Diagnostics : reports 2Q loss (NASDAQ:GNMK) - July 29 at 5:25 PM logoGenMark Diagnostics : to Present at the 36th Annual Canaccord Genuity Growth Conference (NASDAQ:GNMK) - July 28 at 9:46 PM logoGenMark Diagnostics Reports Q2 Financial Results (NASDAQ:GNMK) - July 28 at 9:46 PM logoGenMark Diagnostics reports 2Q loss (NASDAQ:GNMK) - July 28 at 6:18 PM logoQ2 2016 GenMark Diagnostics Inc Earnings Release - After Market Close (NASDAQ:GNMK) - July 28 at 7:07 AM logoGenMark Diagnostics to Present at the 36th Annual Canaccord Genuity Growth Conference (NASDAQ:GNMK) - July 27 at 5:48 PM logoExpected For GenMark Diagnostics, Inc. (NASDAQ:GNMK) Sales Of $66.845 - Investor Newswire (NASDAQ:GNMK) - July 25 at 5:20 PM logoIs $15 Price Target Attainable For GenMark Diagnostics, Inc. (NASDAQ:GNMK)? - Investor Newswire (NASDAQ:GNMK) - July 24 at 9:42 AM logoETF’s with exposure to GenMark Diagnostics, Inc. : July 21, 2016 (NASDAQ:GNMK) - July 21 at 2:04 PM
News IconGenmark Diagnostics Incorporated (NASDAQ:GNMK) Shorted Shares Increased By 0.98% - Consumer Eagle (NASDAQ:GNMK) - July 21 at 8:50 AM
News IconWere Analysts Bearish GenMark Diagnostics, Inc (NASDAQ:GNMK) This Week? - Consumer Eagle (NASDAQ:GNMK) - July 19 at 11:24 AM logoGenMark Diagnostics, Inc. (NASDAQ:GNMK) Expected To Post Sales Of $66.845 - Investor Newswire (NASDAQ:GNMK) - July 18 at 5:29 PM
News IconShare Performance Summary for: GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Press Telegraph (NASDAQ:GNMK) - July 18 at 5:29 PM
News IconShares Moving Down on the Week: GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Engelwood Daily (NASDAQ:GNMK) - July 17 at 4:53 PM
News IconShares Experiencing a Downtrend: GenMark Diagnostics, Inc. (NASDAQ:GNMK) - TGP (NASDAQ:GNMK) - July 16 at 5:04 PM
News IconCrowd Rating and Earnings Recap for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Telanagana Press (NASDAQ:GNMK) - July 15 at 4:17 PM
News IconGenmark Diagnostics Incorporated (NASDAQ:GNMK) Sellers Increased By 0.65% Their Shorts - Consumer Eagle (NASDAQ:GNMK) - July 14 at 5:25 PM logoGenMark Diagnostics Schedules Second Quarter 2016 Financial Results Conference Call for July 28, 2016 (NASDAQ:GNMK) - July 14 at 5:12 PM
News IconGenMark Diagnostics, Inc. (NASDAQ:GNMK) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:GNMK) - July 14 at 8:43 AM
News IconGenMark Diagnostics, Inc. (NASDAQ:GNMK) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:GNMK) - July 12 at 9:40 AM logoGenMark Diagnostics, Inc. (NASDAQ:GNMK) Yearly Sales Target At $66.845 - Investor Newswire (NASDAQ:GNMK) - July 12 at 9:40 AM
News IconTrading Performance and Target Watch for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Press Telegraph (NASDAQ:GNMK) - July 12 at 9:40 AM logoNew Broker Ratings For GenMark Diagnostics, Inc. (GNMK) - FTSE News (NASDAQ:GNMK) - July 12 at 9:40 AM
News IconWall Street Ratings and Target Price Views on GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Telanagana Press (NASDAQ:GNMK) - July 10 at 9:42 AM logoIs $15 Within Reach For GenMark Diagnostics, Inc. (NASDAQ:GNMK)? - Investor Newswire (NASDAQ:GNMK) - July 8 at 5:14 PM
News IconHeightened Volatility Check on: GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Engelwood Daily (NASDAQ:GNMK) - July 7 at 5:19 PM logoBroker Outlook For GenMark Diagnostics, Inc. (GNMK) - Fiscal Standard (NASDAQ:GNMK) - July 7 at 5:19 PM
News IconTime to Buy GenMark Diagnostics, Inc After Today's Huge Increase? - Press Telegraph (NASDAQ:GNMK) - July 7 at 8:06 AM
News IconStock Rating Watch and Earnings Insight for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Press Telegraph (NASDAQ:GNMK) - July 7 at 8:06 AM
News IconWere Analysts Bearish GenMark Diagnostics, Inc (NASDAQ:GNMK) This Week? - Press Telegraph (NASDAQ:GNMK) - July 5 at 5:08 PM logoGenMark Diagnostics, Inc. (NASDAQ:GNMK) Expected to Reach Highs Of $15 - Investor Newswire (NASDAQ:GNMK) - July 2 at 8:11 AM
News IconGenmark Diagnostics Incorporated (NASDAQ:GNMK) Shorted Shares Increased 0.65% After Market Selling - Press Telegraph (NASDAQ:GNMK) - July 1 at 8:02 AM logoGenMark Diagnostics, Inc. (GNMK) Current Analyst Ratings - Fiscal Standard (NASDAQ:GNMK) - July 1 at 8:02 AM
News IconShare Update and Earnings Review for GenMark Diagnostics, Inc. (NASDAQ:GNMK) - Press Telegraph (NASDAQ:GNMK) - June 30 at 8:05 AM
News IconGenMark Diagnostics, Inc. (NASDAQ:GNMK) Company Rating and Target Watch - Telanagana Press (NASDAQ:GNMK) - June 30 at 8:05 AM
News IconGenMark Diagnostics, Inc. (NASDAQ:GNMK) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:GNMK) - June 28 at 10:04 AM logoBroker Outlook For The Week Ahead GenMark Diagnostics, Inc. (GNMK) - Fiscal Standard (NASDAQ:GNMK) - June 27 at 5:08 PM


GenMark Diagnostics (NASDAQ:GNMK) Chart for Saturday, August, 27, 2016

Last Updated on 8/27/2016 by Staff